2 completed, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Placebo 400 mg: new trials by email Literature Review of Placebo 400 mg trials Research Report on Placebo 400 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes Placebo 400 mg, Dihydroberberine（DHB）400 mg - Prediabetes | Not applicable | Recruiting | Nanjing Nutrabuilding Bio-tech Co., Ltd. | 54 | 2025-08-06 | 2025-10-07 |
| The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers. ZSP1273 100 mg, Placebo 100 mg, ZSP1273 200 mg - Influenza | Phase 1 | Completed | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 103 | 2018-09-20 | 2019-08-14 |
| Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis Albaconazole 100mg, Albaconazole 200mg, Albaconazole 400mg - Onychomycosis | Phase 2 | Completed | Stiefel, a GSK Company | 582 | 2008-07-16 | 2018-03-12 |
Influenza, Human (1) · Onychomycosis (1) · Prediabetic State (1)
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (1) · Nanjing Nutrabuilding Bio-tech Co., Ltd. (1) · Stiefel, a GSK Company (1)
United States (2) · Canada (1) · China (1) · Iceland (1)
Elizabeth Antoo, MD (1) · Shucheng Hua, MD (1) · Yanhua Ding, MD (1)